MAIA Biotechnology, Inc. (MAIA)Healthcare | Biotechnology | Chicago, United States | NYSE American
1.16 USD
-0.02
(-1.695%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 1.17 +0.01 (0.862%) ⇧ (Oct. 13, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 7:36 a.m. EDT
The immediate outlook is bearish due to a distinct lack of price momentum and deteriorating technical structure. Over the last two months, the stock has drifted lower, trading significantly below both its 50-day and 200-day averages, indicating that sellers are in control despite recent positive news headlines. While executives buying shares suggests internal confidence in the long-term science, the market is currently pricing in significant execution risk regarding the upcoming Phase 3 trial; the stock has already fallen nearly 56% over the past three years, reflecting deep skepticism about the commercial viability of the pipeline. The statistical forecast model offers no directional edge, confirming that short-term price action is likely to remain range-bound or drift lower without a catalyst. There is no dividend income to offset these risks, making this a speculative hold at best rather than an investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.066015 |
| AutoETS | 0.079372 |
| AutoARIMA | 0.079374 |
| AutoTheta | 0.090766 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 0.57 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.183 |
| Excess Kurtosis | -0.16 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 71,620,656 |
| Forward P/E | 1.05 |
| Beta | 0.28 |
| Website | https://maiabiotech.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.18055558 |
| Address1 | 444 West Lake Street |
| Address2 | Suite 1700 |
| All Time High | 9.64 |
| All Time Low | 0.82 |
| Ask | 0.0 |
| Ask Size | 2,100 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 495,320 |
| Average Daily Volume3 Month | 496,639 |
| Average Volume | 496,639 |
| Average Volume10Days | 495,320 |
| Beta | 0.281 |
| Bid | 0.0 |
| Bid Size | 4,100 |
| Book Value | 0.34 |
| City | Chicago |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.16 |
| Current Ratio | 4.512 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.18 |
| Day Low | 1.15 |
| Display Name | MAIA Biotechnology |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,754,683,200 |
| Earnings Timestamp Start | 1,754,683,200 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 42,962,148 |
| Eps Current Year | -0.54 |
| Eps Forward | 1.11 |
| Eps Trailing Twelve Months | -0.62 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.3154 |
| Fifty Day Average Change | -0.15540004 |
| Fifty Day Average Change Percent | -0.118139 |
| Fifty Two Week Change Percent | -18.055557 |
| Fifty Two Week High | 3.19 |
| Fifty Two Week High Change | -2.0300002 |
| Fifty Two Week High Change Percent | -0.6363637 |
| Fifty Two Week Low | 0.87 |
| Fifty Two Week Low Change | 0.28999996 |
| Fifty Two Week Low Change Percent | 0.33333328 |
| Fifty Two Week Range | 0.87 - 3.19 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,659,015,000,000 |
| Float Shares | 55,296,775 |
| Forward Eps | 1.11 |
| Forward P E | 1.045045 |
| Free Cashflow | -13,788,294 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 13 |
| Fullday Change | -0.00999999 |
| Fullday Change Percent | -0.8474569 |
| Fullday Price | 1.16 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14406 |
| Held Percent Institutions | 0.21905 |
| Implied Shares Outstanding | 61,741,946 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois. |
| Long Name | MAIA Biotechnology, Inc. |
| Market | us_market |
| Market Cap | 71,620,656 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_631239285 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -26,845,188 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 80,301,151 |
| Number Of Analyst Opinions | 2 |
| Open | 1.18 |
| Operating Cashflow | -22,568,370 |
| Operating Margins | 0.0 |
| Phone | 312 416 8592 |
| Post Market Change | 0.00999999 |
| Post Market Change Percent | 0.8620682 |
| Post Market Price | 1.17 |
| Post Market Time | 1,791,934,204 |
| Previous Close | 1.18 |
| Price Eps Current Year | -2.148148 |
| Price Hint | 4 |
| Price To Book | 3.4117646 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.41 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.02 |
| Regular Market Change Percent | -1.69491 |
| Regular Market Day High | 1.18 |
| Regular Market Day Low | 1.15 |
| Regular Market Day Range | 1.15 - 1.18 |
| Regular Market Open | 1.18 |
| Regular Market Previous Close | 1.18 |
| Regular Market Price | 1.16 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 277,464 |
| Return On Assets | -0.92098 |
| Return On Equity | -2.18683 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 61,741,946 |
| Shares Percent Shares Out | 0.0436 |
| Shares Short | 2,690,687 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 2,347,365 |
| Short Name | MAIA Biotechnology, Inc. |
| Short Percent Of Float | 0.0475 |
| Short Ratio | 4.06 |
| Source Interval | 15 |
| State | IL |
| Symbol | MAIA |
| Target High Price | 14.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 12.0 |
| Target Median Price | 12.0 |
| Total Cash | 27,595,832 |
| Total Cash Per Share | 0.454 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.62 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.4888 |
| Two Hundred Day Average Change | -0.32880008 |
| Two Hundred Day Average Change Percent | -0.22084905 |
| Type Disp | Equity |
| Volume | 277,464 |
| Website | https://maiabiotech.com |
| Zip | 60,606 |